Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Mol Nutr Food Res ; 55(7): 1070-8, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21538849

ABSTRACT

SCOPE: To characterize the effects of ingesting the common foodborne mycotoxin deoxynivalenol (DON) on body weight and composition in the high-fat (HF) diet-induced obese mice, a model of human obesity. METHODS AND RESULTS: Female B6C3F1 mice were initially fed HF diets containing 45% kcal (HF45) or 60% kcal (HF60) as fat for 94 days to induce obesity. Half of each group was either continued on unamended HF diets or fed HF diets containing 10 mg/kg DON (DON-HF45 or DON-HF60) for another 54 days. Additional control mice were fed a low-fat (LF) diet containing 10% kcal as fat for the entire 148-day period. DON induced rapid decreases in body weights and fat mass, which stabilized to those of the LF control within 11 days. These effects corresponded closely to a robust transient decrease in food consumption. While lean body mass did not decline in DON-fed groups, further increases were suppressed. DON exposure reduced plasma insulin, leptin, insulin-like growth factor 1, and insulin-like growth factor acid labile subunit as well as increased hypothalamic mRNA level of the orexigenic agouti-related protein. CONCLUSION: DON-mediated effects on body weight, fat mass, food intake, and hormonal levels in obese mice were consistent with a state of chronic energy restriction.


Subject(s)
Body Composition/drug effects , Body Weight/drug effects , Obesity/metabolism , Trichothecenes/pharmacology , Adipose Tissue/drug effects , Agouti-Related Protein/drug effects , Agouti-Related Protein/genetics , Animals , Carrier Proteins/blood , Carrier Proteins/drug effects , Dietary Fats/toxicity , Eating/drug effects , Energy Intake/drug effects , Female , Glycoproteins/blood , Glycoproteins/drug effects , Hypothalamus/drug effects , Hypothalamus/physiology , Insulin/blood , Insulin-Like Growth Factor I/drug effects , Leptin/blood , Mice , Mice, Obese , Obesity/chemically induced , Obesity/drug therapy , RNA, Messenger
SELECTION OF CITATIONS
SEARCH DETAIL